参考文献/References:
[1]Glotzbecker MP, Carpentieri DF, Dormans JP. Langerhans cell histiocytosis: a primary viral infection of bone? Human herpes virus 6 latent protein detected in lymphocytes from tissues of children. J Pediatr Orthop,2004,24(1):123-129.
[2]NgChengHin B, O’hanlonBrown C, Alifrangis C, et al. Langerhans cell histiocytosis: old disease new treatment. QJM,2011,104(2):89-96.
[3]许霞,刘卫平,杨群培,等.Langerhans细胞组织细胞增生症258例临床病理特征和免疫表型分析.中华病理学杂志,2012,41(2):91-96.
[4]Arico M, Girschikofsky M, Genereau T, et al. Langerhans cell histiocytosis in adults report from the International Registry of the Histiocyte Society. Eur J Cancer,2003,39(16):2341-2348.
[5]Valladeau J, Ravel O, DezutterDambuyant C, et al. Langerin, a novel Ctype lectin specific to Langerhans cells, is an endocytic receptor that induces the foramtion of Birbeck granules. Immunity,2000,12(1):71-81.
[6]Cantu MA, Lupo PJ, Bilgi M, et al. Optimal therapy for adults with Langerhans cell histiocosis bone lesions. PLoS One,2012,7(8):e43257．
[7]Elia D, Tollre O, Cassandro R, et al. Pulmonary Langerhans cell histiocytosis: A comprehensive analysis of 40 patients and literature review. Eur J Inter Med,2015,26(5):351-356．
[8]Chang JC, Blake DG, Leung BV, et al. Langerhans cell histioccyosis associated with lichen sclerosus of the vulva: case report and review of the literature. J Cutan Pathol,2013,40(2):279-283．
[9]张爱妹.成人肺朗格罕斯细胞组织细胞增生症一例.中国呼吸与危重监护杂志,2010,9(1):92-93．
[10]王雪萍,刘辉.女性生殖系统郎格罕氏组织细胞增生症4例临床分析.四川大学学报(医学版),2014,45(3):536-538．
[11]Egeler RM, de Kraker J, Voute PA. Cytosinearabinoside, vincristine, and prednisolone in the treatment of children with disseminated Langerhans cell histiocytosis with organ dysfunction：experience at a single institution. Med Pediatr Oncol,1993,21(4):265-270．
[12]Kilpatrick SE, Wenger DE, Gilchrist GS, et al. Langerhans’ cell histiocytosis (histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult cases. Cancer,1995,76(12):2471-2484．
[13]Szurz P, Adam Z, Rehak Z, et al. Lenalidomide proved effective in multisystem Langerhans cell histiocytosis. Acta Oncol,2012,51(3):412-415．
[14]Berres ML, Lim KP, Peters T, et al. BRAF V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. J Exp Med,2014,211(4):669-683．
[15]Le PJ, Lorillon G, Jais X, et al. Pulmonary Langerhans cell histiocytosisassociated pulmonary hypertension: clinical characteristics and impact of pulmonary arterial hypertension therapies. Chest,2012,142(5):1150-1157.
[16]Weizman S, Braier J, Donadieu J, et al. 2’Chlorodeoxyadenosine(2CdA) as salvage therapy for Langerhans cell histiocytosis(LCH). results of the LCHS98 protocol of the Histiocyte Society. Pediatric Blood Cancer,2009,53(7):1271-1276.